Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance

2025 ICD-10-CM code A30.2

Borderline tuberculoid leprosy (BT leprosy).

Use additional codes to identify resistance to antimicrobial drugs (Z16.-) if applicable.

Medical necessity for treatment is established by confirming the diagnosis of borderline tuberculoid leprosy through clinical findings and laboratory tests (biopsy). Treatment aims to prevent disease progression, reduce morbidity (nerve damage, disability), and prevent transmission.

Clinicians should evaluate patients for symptoms similar to tuberculoid leprosy, including skin lesions, nerve enlargement (though less prominent in this form), and potential progression to other forms. Diagnosis involves physical examination, skin/nerve biopsy, and assessment of neurological symptoms. Treatment includes multi-drug antibiotic therapy and anti-inflammatory medications.

In simple words: Borderline tuberculoid leprosy is a type of leprosy that is similar to tuberculoid leprosy, but with less nerve damage and smaller skin lesions. This type of leprosy can either stay the same, improve, or worsen over time. Leprosy is a bacterial infection that can cause skin discoloration, lumps, ulcers, and nerve damage.

A form of leprosy similar to tuberculoid leprosy, but with less nerve enlargement and smaller, more numerous lesions. It can progress to the tuberculoid form or other forms of leprosy.Leprosy is a slow-growing bacterial infection caused by Mycobacterium leprae, typically affecting the nerves, skin, eyes, and nasal mucosa.

Example 1: A patient presents with multiple small, hypopigmented skin lesions and some sensory loss but with less nerve thickening than typically seen in tuberculoid leprosy. Biopsy confirms Mycobacterium leprae, and the patient is diagnosed with borderline tuberculoid leprosy., A patient initially diagnosed with indeterminate leprosy shows progression to borderline tuberculoid leprosy with the development of more defined skin lesions and mild nerve involvement., A patient with borderline tuberculoid leprosy undergoes multi-drug antibiotic therapy and experiences improvement in skin lesions and neurological symptoms, with the disease stabilizing in the tuberculoid form.

Documentation should include detailed descriptions of skin lesions (size, number, location, color, sensory changes), nerve involvement (thickening, tenderness, sensory/motor deficits), biopsy results, and treatment response.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.